Cytoreductive Surgery (CRS) is a surgical procedure used to remove cancer cells from the body. It is typically used in combination with other treatments such as chemotherapy and radiation therapy. The goal of CRS is to reduce the number of cancer cells in the body and thereby improve the chances of survival. CRS involves removing the tumor, along with the surrounding tumor tissue and lymph nodes. This is done by making an incision in the skin and cutting away the cancerous tissue. In some cases, the entire organ may need to be removed. This is known as an organ resection. CRS may be used to treat cancer in many different organs, such as the ovaries, lungs, liver, pancreas, and colon. It is most often used for ovarian cancer, but may be used for other types of cancer as well. CRS is a complex procedure and is often used in combination with other treatments. The procedure can be lengthy and the recovery time can be long. The risks associated with CRS include infection, bleeding, and damage to surrounding organs.
Title : Evaluate the changes in SP-D levels in plasma during different phases of the menstrual cycle recruited from the Well- Adult Surfactant Protein Study (WASP)
Natnicha Kitti udom, University College London, Thailand
Title : Synergistic antifibrotic potential of protocatechuic acid and D-Carvone in liver protection
Ling Yin, Hefei Comprehensive National Science Center, China
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin-Khameh, Baylor College of Medicine, United States
Title : Non-ablative radiofrequency for pelvic floor dysfunction and female intimate anti-aging: a 6-month prospective multi-centre cohort objectiv
Shaadaiti Wufuer, First Affiliated Hospital of Xinjiang Medical University, China
Title : Benign gynecological conditions and lifetime contraceptive patterns: a population-based analysis of the 2022–2023 national survey of family growth
Mayi Gnofam, Stony Brook University, United States
Title : Hysteroscopic endometrial resection with resectoscope versus Novasure ablation: A look at patient satisfaction with treatment of abnormal uterine bleeding and rates of progression to hysterectomy
Genevieve Kan, West Gippsland Healthcare Group, Australia